13F-HR filed by Lamond Capital Partners LLC
Lamond Capital Partners LLC filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-13, with 15 holding rows worth $152,691,000.
- Accession
- 0001542550-15-000002
- Filer
- CIK 1542550
- Filed
- 2015-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2014
A holdings report, 15 entries on the cover page, a total value of $152,691,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $152,689,000 with VALUE read as thousands by filing date, 13F file number 028-15156. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INFOBLOX INC | 45672H104 | COM | 1,495,906 | $30,232,000 | thousands by filing date | |
| KITE PHARMA INC | 49803L109 | COM | 365,900 | $21,101,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 147,380 | $13,518,000 | thousands by filing date | |
| RALLY SOFTWARE DEV CORP COM | 751198102 | COM | 1,163,626 | $13,230,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 135,870 | $12,807,000 | thousands by filing date | |
| OREXIGEN THERAPEUTICS INC | 686164104 | COMMON STOCK | 1,891,000 | $11,459,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 55,005 | $10,411,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 134,230 | $9,085,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 91,840 | $8,302,000 | thousands by filing date | |
| Salesforce.com, Inc | 79466L302 | COM | 127,970 | $7,590,000 | thousands by filing date | |
| AOL INC | 00184X105 | COM | 128,850 | $5,949,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 77,940 | $3,420,000 | thousands by filing date | |
| RINGCENTRAL INC | 76680R206 | CL A | 161,424 | $2,408,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 74,380 | $1,749,000 | thousands by filing date | |
| SYNAGEVA BIOPHARMA CORP | 87159A103 | COM | 15,390 | $1,428,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001542550-15-000002 | this filing | 2015-02-13 | acceptance time not in the bulk data set |